AstraZeneca Strikes AI Drug Discovery Deal Worth Up to $1.5 Billion
AstraZeneca said it will work with Insitro to use AI to explore treatments for cardiometabolic diseases. The deal includes $40 million upfront, with additional payments bringing its value to as much as $1.5 billion.